Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis
Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This randomised trial plans to compare oral tofacitinib with intravenous cyclosporine in
patients with acute severe ulcerative colitis who have failed to respond to intravenous
steroids
Phase:
N/A
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research
Collaborator:
All India Institute of Medical Sciences, New Delhi